A THC-Positive Driver Case Series Did Not Supply a Drug-Free Specificity Group

A study selected from THC-positive driver investigations cannot establish drug-free specificity without a suitable negative comparison group. A two-year case review provides useful observations within its selected cases, but it does not answer every diagnostic-accuracy question.

Selection happened before the final analysis

Declues and colleagues began with THC-positive cases from suspected drug-driving investigations. They excluded cases for reasons including insufficient blood, other drugs or suspected untested substances, and incomplete or unsuitable records. The final analysis included 363 selected cases.

That process produced a narrower group for examining driving observations and field sobriety findings. It did not create a representative sample of all drivers or a control group of drivers without THC.

A positive case series cannot fill every cell

Specificity concerns how often a test is negative among people without the target condition. To estimate it, the study needs observations from that comparison group using an appropriate reference definition.

Finding field-test signs frequently in THC-positive cases does not establish how often the same signs occur without THC. Nor is THC positivity itself a direct reference for functional impairment. These distinctions remain necessary even when known additional drugs have been excluded.

Preserve the reported finding and its limits

The study reported no correlation between THC concentration and field-test performance in its selected sample. That finding cautions against a simple concentration-to-performance rule; it does not demonstrate that cannabis has no driving effects.

The article can inform discussion of observed THC-positive investigations. It cannot supply a drug-free false-positive rate from a group it did not include. A useful interpretation identifies both the selection process and the outcome before quoting sensitivity or specificity.

Related: How the reference specimen changes a cannabis accuracy claim.

Research cited

Declues K; Perez S; Figueroa A; Journal of Forensic Sciences; 2016. A 2-Year Study of Delta-9-tetrahydrocannabinol Concentrations in Drivers: Examining Driving and Field Sobriety Test Performance.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Living-Subject Cannabis Blood-Fraction Ratio Did Not Validate Postmortem Conversion

A plasma-to-whole-blood relationship observed in living cannabis users did not validate the same conversion after death. Giroud and colleagues found substantially greater variability in postmortem samples and cautioned against applying an exposure-time model in that setting. The study compared different blood fractions The investigators examined cannabinoid measurements in eight living…

Spread the love

Read Article: A Living-Subject Cannabis Blood-Fraction Ratio Did Not Validate Postmortem Conversion

A Cannabis Muscle-Tone Opinion Needs a Defined Measurement Method

A statement that someone’s muscle tone indicates cannabis impairment needs a defined observation and measurement method. A published perspective questions whether a subjective limb assessment can carry the same meaning as a standardized clinical evaluation. The critique concerns what was measured The perspective contrasts descriptions such as normal, rigid or…

Spread the love

Read Article: A Cannabis Muscle-Tone Opinion Needs a Defined Measurement Method

A THC-Positive Driver Case Series Did Not Supply a Drug-Free Specificity Group

A study selected from THC-positive driver investigations cannot establish drug-free specificity without a suitable negative comparison group. A two-year case review provides useful observations within its selected cases, but it does not answer every diagnostic-accuracy question. Selection happened before the final analysis Declues and colleagues began with THC-positive cases from…

Spread the love

Read Article: A THC-Positive Driver Case Series Did Not Supply a Drug-Free Specificity Group

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us